Computer Science · Computational Theory and Mathematics
G protein contribution to complex signaling pathways downstream of the dopamine D2L receptor (662.10)
Tarsis F. Brust, Michael P. Hayes, David L. Roman, Val J. Watts
See on the mapAbstract
The dopamine D2 receptor (D2R) is a drug target that activates multiple signaling pathways via G protein‐dependent and independent mechanisms. Different ligands can activate these signaling pathways with distinct potencies and efficacies (i.e. biased ligands) which may provide a path for developing safer and more effective therapies. The present study examined several complex signaling pathways that may require multiple immediate effectors of the D2R. Specifically, we analyzed ERK phosphorylation, heterologous sensitization, AKT phosphorylation, and dynamic mass redistribution in response to a series of D2R ligands. The ligands tested included previously characterized D2R modulators that are used for the treatment of Parkinson’s disease and schizophrenia. The results were compared to previous studies examining Gαi/o, Gβγ, and β‐arrestin signaling in the same model system. Ligand bias was assessed using previously described methods as well as a new Weighted Efficacy Analysis (WEA). The WEA utilizes a straightforward equation incorporating two key pharmacological measures (i.e. pEC50 and relative efficacy) to calculate bias. Additional studies explored the requirement of both Gαi/o and Gβγ activation for these complex signaling pathways. Our results reveal unique bias profiles of several D2R ligands and provide insight regarding the effector requirements for complex signaling pathways of the D2R. Grant Funding Source : Supported by MH60397 and BBRF.